• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Raptor Pharmaceutical Corp

+ Add to Watchlist

XYXR:GR

8.586 EUR 0.521 6.46%

As of 11:34:36 ET on 10/24/2014.

Snapshot for Raptor Pharmaceutical Corp (XYXR)

Open: 8.415 Day's Range: 8.415 - 8.586 Volume: 0
Previous Close: 8.065 52wk Range: 5.332 - 13.865 1-Yr Rtn: -18.08%

Stock Chart for XYXR

No chart data available.
  • XYXR:GR 8.586
  • 1M
  • 1Y
8.065
Interactive XYXR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XYXR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.7220
Est. PEG Ratio -
Market Cap (M EUR) 538.71
Shares Outstanding (M) 62.74
30 Day Average Volume 92
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XYXR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XYXR

Raptor Pharmaceuticals Corporation provides medical research services. The Company develops, manufactures, and commercializes medicines and clinical treatment for neurodegenerative disorder and liver disease. Raptor Pharmaceuticals serves the medical field worldwide.

Christopher M StarrCEO/Co-FounderJulie Anne SmithPresident/CEO-Designate
David HappelChief Commercial OfficerThomas E Daley "Ted"Chief Business Officer
More Company Profile & Key Executives for XYXR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil